期刊文献+

血栓弹力图评价老年患者抗血小板治疗的临床意义 被引量:1

Clinical significance of thrombelastogram for the assessment of antiplatelet treatment in the elderly
原文传递
导出
摘要 目的应用血栓弹力图观察我院老年患者服用抗血小板药物后血小板抑制率的变化情况。方法选择我院门诊和住院的62例抗血小板治疗的老年患者,并将患者分成阿司匹林组、氯吡格雷组、阿司匹林+氯吡格雷组,16例未服用抗血小板药物的患者为对照组,应用血栓弹力图仪分别测得4组花生四烯酸(AA)和二磷酸腺苷(ADP)途径诱导的血小板抑制率值,并进行比较分析。结果阿司匹林组AA诱导的血小板抑制率为(78.93±11.73)%,氯吡格雷组ADP诱导的血小板抑制率为(53.4±21.5)%,阿司匹林+氯吡格雷组AA诱导和ADP诱导的血小板抑制率分别为(93.27±5.73)%和(55.8±24.6)%,血小板抑制率均显著高于对照组(P<0.01)。结论血栓弹力图能客观反映老年患者服用抗血小板药物后血小板抑制率的变化。阿司匹林能起到较好的抗血小板作用,其抗血小板作用优于氯吡格雷,同时服用阿司匹林和氯吡格雷能起到更有效的抗血小板作用。 Objective To observe the changes of platelet inhibition rate by thrombelastogram in the elderly patients receiving anti-platelet treatment. Methods Sixty-two elderly patients receiving anti-platelet treatment in our hospital were divided into 3 groups( aspirin group,clopidogrel group and aspirin combined with clopidogrel group) according to the anticoagulants. Sixteen elderly patients who did not receive anti-platelet treatment were enrolled as control group. All patients underwent the detection of thrombelastogram. The levels of platelet inhibition rate were analyzed and compared between four groups. Results The platelet inhibition rate induced by arachidonic acid( AA) in aspirin group was( 78. 93± 11. 73) %,and the platelet inhibition rate induced by adenosine diphosphate( ADP) in clopidogrel group was( 53. 4 ±21. 5) %. The platelet inhibition rate induced by AA or ADP in aspirin combined with clopidogrel group was( 93. 27 ±5. 73) % and( 55. 8 ± 24. 6) %,respectively. The platelet inhibition rate in the above three groups were higher than that in control group significantly( P〈0. 01). Conclusions Thrombelastogram can reflect the changes of platelet inhibition rate. The effects of aspirin for antiplatelet are better than clopidogrel. Cooperation of aspirin and clopidogrel can inhibit platelet aggregation more effectively.
出处 《实用老年医学》 CAS 2015年第6期504-506,共3页 Practical Geriatrics
关键词 血栓弹力图 血小板抑制率 阿司匹林 氯吡格雷 thrombelastogram platelet inhibition rate aspirin clopidogrel
  • 相关文献

参考文献8

二级参考文献32

  • 1李海文,杨志明,萧传实.冠状动脉粥样硬化斑块稳定性鉴别的研究进展[J].心血管病学进展,2005,26(6):581-585. 被引量:23
  • 2Rezekalla SH,Kloner RA.No-reflow phenomenon[J].Circulation,2002,105:656-662.
  • 3Lee DP,Herity NA,Hlatt BL,et al.Adjunctive platelet glycoprotein Ⅱb/Ⅲa imhibition with tirofiban before primary angioplasty improres angiographic outcome:Results of the Tirofiban give in the Emergency Room before primary angioplasty(TIGER-PA) pilot trial[J].Circlation,2003,107:1497.
  • 4Ever D Grech,David R Ramsdale.Acute coronary syndrome:unstable angina and non St segment elevation myocardial infarction.Clinical review[J].BMJ,2003,326:1259-1261.
  • 5De Que iroz Femandes Aran JO,Veleso HH,Braga De paiva JM,et al.Efficacy and of abciximab on acute myocardial infarction inrarction treated with percutaneous coronary infarction inrarction treated with percutaneous coronary in terventions A meta-analysis of randomized controlled trials[J].Am Heart J,2004,148:937-943.
  • 6Singh SK, Suresh MV, Voleti B, et al. The connection between C-reactive protein and atherosclerosis[J]. Ann Med, 2008, 40(2 ):1 10-120.
  • 7Donald M, Lloyd-jones. Narrative Review:Assessment of C- Reactive Protein in Risk Prediction for Cardiovascular Disease [J]. Ann Intern Med, 2006, 145( 1 ):35-42.
  • 8Lee CH, Tan HC, Lim YT. Update on drug-eluting stents for prevention of restenosis [J]. Asian Cardiovasc Thorac Ann, 2006, 14 (1):75-82.
  • 9Sub JW, Koo BK, Zhang SY, et al. Increased risk of atherothrombotic events associated with eytochrome P450 3A5 polymorphism in patients taking elopidogrel. CMAJ, 2006, 174(31): 1715-1722.
  • 10Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogre:lareview of the evidence[J]. JAm Coil Cardiol, 2005, 45(9): 1157-1164.

共引文献102

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部